Literature DB >> 19895175

The utility of 99mTc-EDDA/HYNIC-TOC scintigraphy for assessment of lung lesions in patients with neuroendocrine tumors.

S Pavlovic1, V Artiko, D Sobic-Saranovic, S Damjanovic, B Popovic, R Jakovic, Z Petrasinovic, E Jaksic, M Todorovic-Tirnanic, D Saranovic, M Micev, S Novosel, N Nikolic, V Obradovic.   

Abstract

UNLABELLED: Our aim was to assess clinical utility of 99mTc-EDDA/HYNIC-TOC scintigraphy for evaluation of lung lesions in patients with neuroendocrine tumors (NETs). Single photon emission computed tomography (SPECT) of the thorax and whole body scintigraphy were performed in 34 patients using 99mTc-EDDA/HYNIC-TOC. Visual assessment was complemented by semiquantitative evaluation based on tumor to non-tumor (T/NT) ratio. Clinical, laboratory, and histological findings served as the standard for comparison. Enhanced tracer uptake was observed on both SPECT and whole body scintigraphy in 29 of 34 patients (88% sensitivity). T/NT ratios were significantly higher on SPECT than whole body images (2.96+/-1.07 vs.1.70+/-0.43, p KEYWORDS: 99mTc-EDDA/Hynic-TOC, lung involvement of NETs, T/NT ratio.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 19895175     DOI: 10.4149/neo_2010_01_068

Source DB:  PubMed          Journal:  Neoplasma        ISSN: 0028-2685            Impact factor:   2.575


  1 in total

1.  Predictive Value of 99MTC-hynic-toc Scintigraphy in Lung Neuroendocrine Tumor Diagnosis.

Authors:  Efimia Boutsikou; Konstantinos Porpodis; Vasiliki Chatzipavlidou; Georgia Hardavella; George Gerasimou; Kalliopi Domvri; Nikitas Papadopoulos; Vasiliki Avramidou; Dionisis Spyratos; Theodoros Kontakiotis; Konstantinos Zarogoulidis
Journal:  Technol Cancer Res Treat       Date:  2019-01-01
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.